DALLAS, May 14, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's leading provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2024. The Company's revenue for the quarter ended March 31, 2024, was $5.4 million versus $5.9 million for the quarter ended March 31, 2023, a decrease of 9%. Net loss for the quarter was $0.7 million, or $0.12 per share, compared to a net loss of $0.4 million, or $.07 per share, for the comparable quarter last year. Brian Hullinger, President, and Chief Executive Officer, stated: "Although we experienced a decrease in revenues and earnings for the quarter, we remain optimistic about the future. We continue to actively explore new markets and applications for our hair testing solutions. With a renewed focus on client acquisition, we are confident we are positioning the Company first for revenue stabilization and then for growth." About Psychemedics Corporation Psychemedics Corporation is the ...